First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOC-Reference-Cited by-同舟云学术

First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOC

Published:2021-02-05 Issue:10 Volume:62 Page:1391-1397
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Baum Richard P.,Singh Aviral,Kulkarni Harshad R.,Bernhardt Peter,Rydén Tobias,Schuchardt Christiane,Gracheva Nadezda,Grundler Pascal V.,Köster Ulli,Müller Dirk,Pröhl Michael,Zeevaart Jan Rijn,Schibli Roger,van der Meulen Nicholas P.,Müller Cristina

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference29 articles.

1. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application;Müller;Br J Radiol.,2018

2. A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative

3. Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy;Gracheva;EJNMMI Radiopharm Chem.,2019

4. Future prospects for SPECT imaging using the radiolanthanide terbium-155: production and preclinical evaluation in tumor-bearing mice;Müller;Nucl Med Biol.,2014

5. Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imaging;Müller;EJNMMI Res.,2016

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative study of 155Tb production via 155Dy precursor with p, d and α beams on natural targets for medical applications;Applied Radiation and Isotopes;2024-10

2. Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development;EJNMMI Physics;2024-09-14

3. Internal dosimetry assessment of beta, beta/auger, and alpha decaying radionuclides in targeted radionuclide therapy for prostate cancer: a simulation study;Physica Scripta;2024-07-30

4. Review on the Increasing Role for PSMA-Based Radioligand Therapy in Prostate Cancer;Cancers;2024-07-12

5. Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [¹⁶¹Tb]Tb-PSMA-I&T;Journal of Nuclear Medicine;2024-07-11